Skip Navigation
David Ewing Duncan

David Ewing Duncan

David Ewing Duncan is the author of seven books published in 20 languages. He is a journalist and a television, radio and film producer and correspondent. More

His most recent book is Experimental Man: What one man's body reveals about his future, your health, and our toxic world. He is the Chief Correspondent of public radio's Biotech Nation, and a columnist for Fortune.com. He has been a commentator on NPR's Morning Edition, and a contributing editor for Wired, Discover and Conde Nast Portfolio. David has written for The New York Times, Fortune, National Geographic, Harper's, The Atlantic, and many other publications. He is a former special correspondent and producer for ABC Nightline, and correspondent for NOVA's ScienceNOW! He has won numerous awards including the Magazine Story of the Year from the American Association for the Advancement of Science. His articles have twice been cited in nominations for National Magazine Awards, and his work has appeared twice in The Best American Science and Nature Writing. He is the founding director of the Center of Life Science Policy at UC Berkeley, and a founder of the BioAgenda Institute. He is a graduate of Vassar College and now lives in San Francisco.
The Brain-Computer Interface That Let a Quadriplegic Woman Move a Cup

The Brain-Computer Interface That Let a Quadriplegic Woman Move a Cup

Two severely paralyzed people operated robotic arms and prosthetics using thoughts captured by implants in their brains, a new study disclosed. Inside the brain of a test subject known as S3, a symphony of neurons fired in her motor cortex one day in April last year. Paralyzed by stroke 15 years earlier, this 58 year-old woman with a bright smile and wearing a flashy red shirt imagined that her arm was working again and that it…… More »

Do Genes Really Augur Your Future?

Do Genes Really Augur Your Future?

For some people, genes are key to predicting our future health. For others, genes as crystal balls are overhyped. Let's call it a truce because both sides are right.… More »

Why Do Our Best and Brightest End Up in Silicon Valley and Not D.C.?

Why Do Our Best and Brightest End Up in Silicon Valley and Not D.C.?

A conversation with Google Venture's Bill Maris… More »

Can the Innovator Class Save Healthcare?

Can the Innovator Class Save Healthcare?

TEDMED brought a relentless optimism about healthcare reform to a city of tired ideas. More is needed, however, to make a difference in Washington, DC.… More »

Come Together, Right Now: The Desperate Need for Integration in Biomedicine

Come Together, Right Now: The Desperate Need for Integration in Biomedicine

Two speakers at TEDMED, 82 year-old E.O. Wilson and 34 year-old Jacob Scott, call for a balancing of experts and generalists in life sciences… More »

Whither the Y: The Male Sex Chromosome Is Not Disintegrating

Whither the Y: The Male Sex Chromosome Is Not Disintegrating

The "rotting Y" theory, which suggested a literal end of the male sex chromosome, has finally been debunked by a new study in Nature.… More »

Destroying Medicine to Rebuild It: Eric Topol on Patients Using Data

Destroying Medicine to Rebuild It: Eric Topol on Patients Using Data

In his new book, the cardiologist and director of the Scripps Translational Science Institute is on a tear to transform health using the latest tech.… More »

Thanks to Julius Caesar, Leap Day is Costing Us $3.5 Billion

Thanks to Julius Caesar, Leap Day is Costing Us $3.5 Billion

An extra day means an extra day of interest on your debts.… More »

Redesigning People: How Medtech Could Expand Beyond the Injured

Redesigning People: How Medtech Could Expand Beyond the Injured

Radical human modification is coming, like it or not, by the end of this century -- if not earlier. How much are you willing to alter yourself?… More »

View All Correspondents

The Biggest Story in Photos

Olympic Portraits, Part I: American Athletes

May 30, 2012

Subscribe Now

SAVE 59%! 10 issues JUST $2.45 PER COPY

Facebook

Newsletters

Sign up to receive our free newsletters

(sample)

(sample)

(sample)

(sample)

(sample)

(sample)